Gilbert, L., Muzaffar, J., Velcheti, V., Spreafico, A., Calvo, E., McDermott, D. F., . . . Chu, Q. S. Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1). BMJ Publishing Group.
Chicago Style (17th ed.) CitationGilbert, Lucy, et al. Nemvaleukin Alfa, a Modified Interleukin-2 Cytokine, as Monotherapy and with Pembrolizumab in Patients with Advanced Solid Tumors (ARTISTRY-1). BMJ Publishing Group.
MLA (9th ed.) CitationGilbert, Lucy, et al. Nemvaleukin Alfa, a Modified Interleukin-2 Cytokine, as Monotherapy and with Pembrolizumab in Patients with Advanced Solid Tumors (ARTISTRY-1). BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.